Mount Sinai and Virginia Commonwealth University researchers have introduced AI-powered platforms—MARQO and Vesalius—that significantly enhance cancer tissue examination and spatial cellular mapping, respectively. By leveraging state-of-the-art image processing and computational oncology, these technologies promise to accelerate pathology workflows and deepen understanding of tumor microenvironments, facilitating precision oncology and targeted treatment development.